Letter from Kidney Care Partners to CMS Regarding Medicare Program; ESRD PPS, Payment for Renal Dialysis Services Furnished to Individuals with AKI, ESRD QIP, DMEPOS (CMS-1691-P); Focus on ESRD QIP (Changing Weight of Measures in Payment Years 2021-2022)
The Kidney Care Partners provides comments to the Centers for Medicare & Medicaid Services (CMS) regarding CMS–1691–P: End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (AKI), End-Stage Renal Disease Quality Incentive Program (QIP), Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) and Fee Schedule Amounts, and Technical Amendments to Correct Existing Regulations Related to the CBP for Certain DMEPOS. This letter focuses on the ESRD QIP proposals related to the measure specifications and the structural recommendations, including the proposals related to changing the weighting of measures in the ESRD QIP, for Payment Years 2021 and 2022.